Product Trade Name: ReNu with Moisture LOC - Multiation Solution. N. Anvisa Reg.: 80136060092 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 BL Indústria Ótica Ltda – Bausch Lomb; Bausch & Lomb 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    822
  • 날짜
    2006-04-10
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    The National Health Surveillance Agency - Anvisa - hereby informs that, to date, there is no report of adverse reactions involving this product in its Database of Notifications of Adverse Events of Health Products. The company BL Indústria Ótica Ltda reported that in Brazil there is, as of today, no case of Fesarium infection involving the product ReNu with Moisture LOC - Multiação Solution. Anvisa will continue to follow the case, in order to ensure that the health products marketed in Brazil have the safety and efficacy necessary for the good performance of the product.//////////Additional information access: http: // www.anvisa.gov.br/tecnovigilancia/alertas/anexos_2006/822.htm
  • 원인
    The us food and drug administration (fda) and the us centers for disease control and prevention (cdc) have published on the fda website at http://www.Fda.Gov/bbs/topics/news/2006/ new01354.Html, an alert to healthcare professionals and contact lens wearers about the growing number of eye infections caused by the fusarium fungus in the united states. although not so frequent in that country, this type of infection is serious, since it can cause permanent blindness. according to the article, some patients reported loss of vision, requiring corneal transplantation. the fda and the cdc are investigating 109 cases of suspected fusarium contamination in 17 us states. the cause has not yet been detected. of the 30 cases investigated, 28 were users of contact lenses and 2 were non-users. of the 28 users, 26 reported using the product contact lens solution brand renu moisture loc, manufactured by the american company bausch & lomb, or a generic company of the same company, within a month before presenting the infection. five other users reported having used other solutions concurrently, and nine patients reported sleeping with their lenses. the alert highlights cases of corneal infection with fusarium fungus in asia in contact lens wearers in november 2005. in february 2006, bausch & lomb voluntarily suspended the sale of renu multipurpose solutions in singapore and hong kong, after the various notifications of infection among contact lens wearers. in brazil the product renu is imported and distributed by the company bl indústria ótica ltda - baush & lomb.
  • 조치
    - In the United States, the CDC is working on investigations with the company Bausch & Lomb to identify other possible causes, in order to act in the prevention and control of this type of infection. - The American Bausch & Lomb Company informed the FDA that it voluntarily halted the marketing of the product ReNu Moisture Loc during the investigation process and requested that all users of contact lenses that make use of the product in question be careful and report to their respective ophthalmologists any signs or symptoms of eye infection. - In Brazil, BL Indústria Ótica Ltda informed Anvisa that it will take the following preventive / corrective actions in relation to the investigation process, which is in progress: 1) Adoption of control measures in the Brazilian territory, implying the suspension of the commercialization of the product in Brazil until the conclusion of the investigations; 2) Send samples of lots that are in the company's stock, for analysis in an external laboratory; 2) Availability, until Monday, April 17, of information on the company's website including a release with the main information. This release is being passed on to all the commercial area of ​​the company BL Indústria Ótica Ltda., For visits to the main clients, aiming to clarify doubts; 3) Definition, until April 17, 2006, of new strategies of action, for the products that are in the stock of the company; 4) Preparation of a document explaining the situation and training of all its SAC team, in order to support the questions and doubts coming from consumers. The company informs that all the contacts are being registered by the SAC and that to the moment no complaint is related to the appearance of fungi. 5) Communication to Anvisa of new facts that affect the current strategy for the treatment of this situation.